Exact Mass: 497.4444

Exact Mass Matches: 497.4444

Found 177 metabolites which its exact mass value is equals to given mass value 497.4444, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

12-Methyldocosanoylcarnitine

3-[(12-Methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C30H59NO4 (497.4444)


12-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 12-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 12-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 12-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

19-Methyldocosanoylcarnitine

3-[(19-methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C30H59NO4 (497.4444)


19-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 19-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 19-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 19-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

21-Methyldocosanoylcarnitine

3-[(21-Methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C30H59NO4 (497.4444)


21-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 21-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 21-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 21-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

13-Methyldocosanoylcarnitine

3-[(13-Methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C30H59NO4 (497.4444)


13-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 13-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 13-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 13-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

9-Methyldocosanoylcarnitine

3-[(9-methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C30H59NO4 (497.4444)


9-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 9-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 9-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 9-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Methyldocosanoylcarnitine

3-[(7-methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C30H59NO4 (497.4444)


7-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 7-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 7-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

17-Methyldocosanoylcarnitine

3-[(17-methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C30H59NO4 (497.4444)


17-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 17-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 17-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 17-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

10-Methyldocosanoylcarnitine

3-[(10-methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C30H59NO4 (497.4444)


10-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 10-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 10-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 10-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Methyldocosanoylcarnitine

3-[(5-methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C30H59NO4 (497.4444)


5-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 5-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

15-Methyldocosanoylcarnitine

3-[(15-Methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C30H59NO4 (497.4444)


15-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 15-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 15-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 15-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Methyldocosanoylcarnitine

3-[(6-Methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C30H59NO4 (497.4444)


6-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 6-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 6-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

20-Methyldocosanoylcarnitine

3-[(20-Methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C30H59NO4 (497.4444)


20-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 20-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 20-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 20-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

16-Methyldocosanoylcarnitine

3-[(16-Methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C30H59NO4 (497.4444)


16-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 16-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 16-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 16-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

8-Methyldocosanoylcarnitine

3-[(8-methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C30H59NO4 (497.4444)


8-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 8-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 8-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 8-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Methyldocosanoylcarnitine

3-[(4-methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C30H59NO4 (497.4444)


4-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 4-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methyldocosanoylcarnitine

3-[(3-Methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C30H59NO4 (497.4444)


3-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 3-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

11-Methyldocosanoylcarnitine

3-[(11-methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C30H59NO4 (497.4444)


11-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 11-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 11-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 11-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

14-Methyldocosanoylcarnitine

3-[(14-methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C30H59NO4 (497.4444)


14-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 14-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 14-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 14-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

18-Methyldocosanoylcarnitine

3-[(18-Methyldocosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C30H59NO4 (497.4444)


18-Methyldocosanoylcarnitine is an acylcarnitine. More specifically, it is an 18-methyldocosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 18-Methyldocosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 18-Methyldocosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(16Z)-14-Hydroxydocos-16-enoylcarnitine

3-[(14-hydroxydocos-16-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C29H55NO5 (497.408)


(16Z)-14-Hydroxydocos-16-enoylcarnitine is an acylcarnitine. More specifically, it is an (16Z)-14-hydroxydocos-16-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (16Z)-14-Hydroxydocos-16-enoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (16Z)-14-Hydroxydocos-16-enoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Tricosanoylcarnitine

3-(tricosanoyloxy)-4-(trimethylazaniumyl)butanoate

C30H59NO4 (497.4444)


Tricosanoylcarnitine is an acylcarnitine. More specifically, it is an tricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Tricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine Tricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

penasin B

penasin B

C30H56ClNO2 (497.3999)


A natural product found in Penares species.

   

Antibiotic Sch 40873

Antibiotic Sch 40873

C24H51N9O2 (497.4166)


   

Cer(d18:0/13:0)

N-(tridecanoyl)-sphinganine

C31H63NO3 (497.4808)


   

Cer[NdS]

N-(tridecanoyl)-sphinganine

C31H63NO3 (497.4808)


   

Tricosanoylcarnitine

Tricosanoylcarnitine

C30H59NO4 (497.4444)


   

9-Methyldocosanoylcarnitine

9-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

7-Methyldocosanoylcarnitine

7-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

5-Methyldocosanoylcarnitine

5-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

6-Methyldocosanoylcarnitine

6-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

8-Methyldocosanoylcarnitine

8-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

4-Methyldocosanoylcarnitine

4-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

3-Methyldocosanoylcarnitine

3-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

12-Methyldocosanoylcarnitine

12-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

19-Methyldocosanoylcarnitine

19-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

21-Methyldocosanoylcarnitine

21-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

13-Methyldocosanoylcarnitine

13-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

17-Methyldocosanoylcarnitine

17-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

10-Methyldocosanoylcarnitine

10-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

15-Methyldocosanoylcarnitine

15-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

20-Methyldocosanoylcarnitine

20-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

16-Methyldocosanoylcarnitine

16-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

11-Methyldocosanoylcarnitine

11-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

14-Methyldocosanoylcarnitine

14-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

18-Methyldocosanoylcarnitine

18-Methyldocosanoylcarnitine

C30H59NO4 (497.4444)


   

(16Z)-14-Hydroxydocos-16-enoylcarnitine

(16Z)-14-Hydroxydocos-16-enoylcarnitine

C29H55NO5 (497.408)


   

N-tetradecanoyl-15-methylhexadecasphinganine

N-tetradecanoyl-15-methylhexadecasphinganine

C31H63NO3 (497.4808)


   

(16Z,19Z,22Z,25Z,28Z)-tetratriacontapentaenoate

(16Z,19Z,22Z,25Z,28Z)-tetratriacontapentaenoate

C34H57O2- (497.4358)


A tetratriacontapentaenoate that is the conjugate base of (16Z,19Z,22Z,25Z,28Z)-tetratriacontapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(19Z,22Z,25Z,28Z,31Z)-tetratriacontapentaenoate

(19Z,22Z,25Z,28Z,31Z)-tetratriacontapentaenoate

C34H57O2- (497.4358)


A polyunsaturated fatty acid anion that is the conjugate base of (19Z,22Z,25Z,28Z,31Z)-tetratriacontapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Cer 18:1;2O/12:0;(2OH)

Cer 18:1;2O/12:0;(2OH)

C30H59NO4 (497.4444)


   

NAGly 17:0/10:0

NAGly 17:0/10:0

C29H55NO5 (497.408)


   

NAGly 10:0/17:0

NAGly 10:0/17:0

C29H55NO5 (497.408)


   

NAGly 11:0/16:0

NAGly 11:0/16:0

C29H55NO5 (497.408)


   

NAGly 12:0/15:0

NAGly 12:0/15:0

C29H55NO5 (497.408)


   

NAGly 16:0/11:0

NAGly 16:0/11:0

C29H55NO5 (497.408)


   

NAGly 14:0/13:0

NAGly 14:0/13:0

C29H55NO5 (497.408)


   

NAGly 13:0/14:0

NAGly 13:0/14:0

C29H55NO5 (497.408)


   

NAGly 15:0/12:0

NAGly 15:0/12:0

C29H55NO5 (497.408)


   

N-(1,3-dihydroxypentacosan-2-yl)hexanamide

N-(1,3-dihydroxypentacosan-2-yl)hexanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxyhexacosan-2-yl)pentanamide

N-(1,3-dihydroxyhexacosan-2-yl)pentanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxydocosan-2-yl)nonanamide

N-(1,3-dihydroxydocosan-2-yl)nonanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxynonan-2-yl)docosanamide

N-(1,3-dihydroxynonan-2-yl)docosanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxyoctacosan-2-yl)propanamide

N-(1,3-dihydroxyoctacosan-2-yl)propanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxyheptacosan-2-yl)butanamide

N-(1,3-dihydroxyheptacosan-2-yl)butanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxytetracosan-2-yl)heptanamide

N-(1,3-dihydroxytetracosan-2-yl)heptanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxyoctan-2-yl)tricosanamide

N-(1,3-dihydroxyoctan-2-yl)tricosanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxytricosan-2-yl)octanamide

N-(1,3-dihydroxytricosan-2-yl)octanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxynonacosan-2-yl)acetamide

N-(1,3-dihydroxynonacosan-2-yl)acetamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxyhenicosan-2-yl)decanamide

N-(1,3-dihydroxyhenicosan-2-yl)decanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxyundecan-2-yl)icosanamide

N-(1,3-dihydroxyundecan-2-yl)icosanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxyicosan-2-yl)undecanamide

N-(1,3-dihydroxyicosan-2-yl)undecanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxydecan-2-yl)henicosanamide

N-(1,3-dihydroxydecan-2-yl)henicosanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxytridecan-2-yl)octadecanamide

N-(1,3-dihydroxytridecan-2-yl)octadecanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxydodecan-2-yl)nonadecanamide

N-(1,3-dihydroxydodecan-2-yl)nonadecanamide

C31H63NO3 (497.4808)


   

Cer 9:0;3O/20:2;(2OH)

Cer 9:0;3O/20:2;(2OH)

C29H55NO5 (497.408)


   

Cer 13:1;3O/16:1;(2OH)

Cer 13:1;3O/16:1;(2OH)

C29H55NO5 (497.408)


   

Cer 13:0;3O/16:2;(2OH)

Cer 13:0;3O/16:2;(2OH)

C29H55NO5 (497.408)


   

Cer 11:0;3O/18:2;(2OH)

Cer 11:0;3O/18:2;(2OH)

C29H55NO5 (497.408)


   

N-(1,3-dihydroxyoctadecan-2-yl)tridecanamide

N-(1,3-dihydroxyoctadecan-2-yl)tridecanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxytetradecan-2-yl)heptadecanamide

N-(1,3-dihydroxytetradecan-2-yl)heptadecanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxypentadecan-2-yl)hexadecanamide

N-(1,3-dihydroxypentadecan-2-yl)hexadecanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxyhexadecan-2-yl)pentadecanamide

N-(1,3-dihydroxyhexadecan-2-yl)pentadecanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxyheptadecan-2-yl)tetradecanamide

N-(1,3-dihydroxyheptadecan-2-yl)tetradecanamide

C31H63NO3 (497.4808)


   

N-(1,3-dihydroxynonadecan-2-yl)dodecanamide

N-(1,3-dihydroxynonadecan-2-yl)dodecanamide

C31H63NO3 (497.4808)


   

N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]hexadecanamide

N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]hexadecanamide

C30H59NO4 (497.4444)


   

(Z)-N-(1,3,4-trihydroxyoctadecan-2-yl)dodec-5-enamide

(Z)-N-(1,3,4-trihydroxyoctadecan-2-yl)dodec-5-enamide

C30H59NO4 (497.4444)


   

N-[(E)-1,3,4-trihydroxyoctadec-8-en-2-yl]dodecanamide

N-[(E)-1,3,4-trihydroxyoctadec-8-en-2-yl]dodecanamide

C30H59NO4 (497.4444)


   

(Z)-N-(1,3,4-trihydroxyheptadecan-2-yl)tridec-8-enamide

(Z)-N-(1,3,4-trihydroxyheptadecan-2-yl)tridec-8-enamide

C30H59NO4 (497.4444)


   

N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]tridecanamide

N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]tridecanamide

C30H59NO4 (497.4444)


   

(Z)-N-(1,3,4-trihydroxyhexadecan-2-yl)tetradec-9-enamide

(Z)-N-(1,3,4-trihydroxyhexadecan-2-yl)tetradec-9-enamide

C30H59NO4 (497.4444)


   

(Z)-N-(1,3,4-trihydroxypentadecan-2-yl)pentadec-9-enamide

(Z)-N-(1,3,4-trihydroxypentadecan-2-yl)pentadec-9-enamide

C30H59NO4 (497.4444)


   

N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]pentadecanamide

N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]pentadecanamide

C30H59NO4 (497.4444)


   

N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]tetradecanamide

N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]tetradecanamide

C30H59NO4 (497.4444)


   

(Z)-N-(1,3,4-trihydroxytetradecan-2-yl)hexadec-7-enamide

(Z)-N-(1,3,4-trihydroxytetradecan-2-yl)hexadec-7-enamide

C30H59NO4 (497.4444)


   

Cer 16:1;3O/13:1;(2OH)

Cer 16:1;3O/13:1;(2OH)

C29H55NO5 (497.408)


   

Cer 17:1;3O/12:1;(2OH)

Cer 17:1;3O/12:1;(2OH)

C29H55NO5 (497.408)


   

Cer 16:1;2O/14:0;(2OH)

Cer 16:1;2O/14:0;(2OH)

C30H59NO4 (497.4444)


   

Cer 17:1;2O/13:0;(3OH)

Cer 17:1;2O/13:0;(3OH)

C30H59NO4 (497.4444)


   

Cer 17:0;2O/13:1;(2OH)

Cer 17:0;2O/13:1;(2OH)

C30H59NO4 (497.4444)


   

Cer 17:0;2O/13:1;(3OH)

Cer 17:0;2O/13:1;(3OH)

C30H59NO4 (497.4444)


   

Cer 14:0;2O/16:1;(2OH)

Cer 14:0;2O/16:1;(2OH)

C30H59NO4 (497.4444)


   

Cer 18:0;2O/12:1;(3OH)

Cer 18:0;2O/12:1;(3OH)

C30H59NO4 (497.4444)


   

Cer 15:1;2O/15:0;(2OH)

Cer 15:1;2O/15:0;(2OH)

C30H59NO4 (497.4444)


   

Cer 14:2;3O/15:0;(2OH)

Cer 14:2;3O/15:0;(2OH)

C29H55NO5 (497.408)


   

Cer 14:1;3O/15:1;(2OH)

Cer 14:1;3O/15:1;(2OH)

C29H55NO5 (497.408)


   

Cer 17:2;3O/12:0;(2OH)

Cer 17:2;3O/12:0;(2OH)

C29H55NO5 (497.408)


   

Cer 15:1;3O/14:1;(2OH)

Cer 15:1;3O/14:1;(2OH)

C29H55NO5 (497.408)


   

Cer 16:1;2O/14:0;(3OH)

Cer 16:1;2O/14:0;(3OH)

C30H59NO4 (497.4444)


   

Cer 14:1;2O/16:0;(3OH)

Cer 14:1;2O/16:0;(3OH)

C30H59NO4 (497.4444)


   

Cer 16:0;2O/14:1;(2OH)

Cer 16:0;2O/14:1;(2OH)

C30H59NO4 (497.4444)


   

Cer 14:1;2O/16:0;(2OH)

Cer 14:1;2O/16:0;(2OH)

C30H59NO4 (497.4444)


   

Cer 17:1;2O/13:0;(2OH)

Cer 17:1;2O/13:0;(2OH)

C30H59NO4 (497.4444)


   

Cer 18:0;2O/12:1;(2OH)

Cer 18:0;2O/12:1;(2OH)

C30H59NO4 (497.4444)


   

Cer 15:2;3O/14:0;(2OH)

Cer 15:2;3O/14:0;(2OH)

C29H55NO5 (497.408)


   

Cer 15:0;2O/15:1;(2OH)

Cer 15:0;2O/15:1;(2OH)

C30H59NO4 (497.4444)


   

Cer 15:1;2O/15:0;(3OH)

Cer 15:1;2O/15:0;(3OH)

C30H59NO4 (497.4444)


   

Cer 16:0;2O/14:1;(3OH)

Cer 16:0;2O/14:1;(3OH)

C30H59NO4 (497.4444)


   

Cer 14:0;2O/16:1;(3OH)

Cer 14:0;2O/16:1;(3OH)

C30H59NO4 (497.4444)


   

Cer 15:0;2O/15:1;(3OH)

Cer 15:0;2O/15:1;(3OH)

C30H59NO4 (497.4444)


   

Cer 16:2;3O/13:0;(2OH)

Cer 16:2;3O/13:0;(2OH)

C29H55NO5 (497.408)


   

Cer 18:1;2O/12:0;(3OH)

Cer 18:1;2O/12:0;(3OH)

C30H59NO4 (497.4444)


   

N-(decanoyl)-heneicosasphinganine

N-(decanoyl)-heneicosasphinganine

C31H63NO3 (497.4808)


   

N-(hexadecanoyl)-pentadecasphinganine

N-(hexadecanoyl)-pentadecasphinganine

C31H63NO3 (497.4808)


   

N-(pentadecanoyl)-hexadecasphinganine

N-(pentadecanoyl)-hexadecasphinganine

C31H63NO3 (497.4808)


   

N-(heptadecanoyl)-tetradecasphinganine

N-(heptadecanoyl)-tetradecasphinganine

C31H63NO3 (497.4808)


   

N-(tetradecanoyl)-heptadecasphinganine

N-(tetradecanoyl)-heptadecasphinganine

C31H63NO3 (497.4808)


   

N-(dodecanoyl)-nonadecasphinganine

N-(dodecanoyl)-nonadecasphinganine

C31H63NO3 (497.4808)


   

N-(tridecanoyl)-sphinganine

N-(tridecanoyl)-sphinganine

C31H63NO3 (497.4808)


   

tetratriacontapentaenoate

tetratriacontapentaenoate

C34H57O2 (497.4358)


A polyunsaturated fatty acid anion that is the conjugate base of tetratriacontapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

AcCa(23:0)

AcCa(23:0)

C30H59NO4 (497.4444)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-2AAA 23:0

NA-2AAA 23:0

C29H55NO5 (497.408)


   

NA-Asp 25:0

NA-Asp 25:0

C29H55NO5 (497.408)


   
   

NA-Glu 24:0

NA-Glu 24:0

C29H55NO5 (497.408)


   
   

CAR 22:1;OH

CAR 22:1;OH

C29H55NO5 (497.408)


   
   

Cer 14:1;O2/16:0;2OH

Cer 14:1;O2/16:0;2OH

C30H59NO4 (497.4444)


   

Cer 14:1;O2/16:0;3OH

Cer 14:1;O2/16:0;3OH

C30H59NO4 (497.4444)


   

Cer 14:1;O2/16:0;O

Cer 14:1;O2/16:0;O

C30H59NO4 (497.4444)


   

Cer 15:1;O2/15:0;2OH

Cer 15:1;O2/15:0;2OH

C30H59NO4 (497.4444)


   

Cer 15:1;O2/15:0;3OH

Cer 15:1;O2/15:0;3OH

C30H59NO4 (497.4444)


   

Cer 15:1;O2/15:0;O

Cer 15:1;O2/15:0;O

C30H59NO4 (497.4444)


   

Cer 16:1;O2/14:0;2OH

Cer 16:1;O2/14:0;2OH

C30H59NO4 (497.4444)


   

Cer 16:1;O2/14:0;3OH

Cer 16:1;O2/14:0;3OH

C30H59NO4 (497.4444)


   

Cer 16:1;O2/14:0;O

Cer 16:1;O2/14:0;O

C30H59NO4 (497.4444)


   

Cer 17:1;O2/13:0;2OH

Cer 17:1;O2/13:0;2OH

C30H59NO4 (497.4444)


   

Cer 17:1;O2/13:0;3OH

Cer 17:1;O2/13:0;3OH

C30H59NO4 (497.4444)


   

Cer 17:1;O2/13:0;O

Cer 17:1;O2/13:0;O

C30H59NO4 (497.4444)


   

Cer 18:1;O2/12:0;2OH

Cer 18:1;O2/12:0;2OH

C30H59NO4 (497.4444)


   

Cer 18:1;O2/12:0;3OH

Cer 18:1;O2/12:0;3OH

C30H59NO4 (497.4444)


   

Cer 18:1;O2/12:0;O

Cer 18:1;O2/12:0;O

C30H59NO4 (497.4444)


   

Cer 19:1;O2/11:0;2OH

Cer 19:1;O2/11:0;2OH

C30H59NO4 (497.4444)


   

Cer 19:1;O2/11:0;3OH

Cer 19:1;O2/11:0;3OH

C30H59NO4 (497.4444)


   

Cer 19:1;O2/11:0;O

Cer 19:1;O2/11:0;O

C30H59NO4 (497.4444)


   

Cer 20:1;O2/10:0;2OH

Cer 20:1;O2/10:0;2OH

C30H59NO4 (497.4444)


   

Cer 20:1;O2/10:0;3OH

Cer 20:1;O2/10:0;3OH

C30H59NO4 (497.4444)


   

Cer 20:1;O2/10:0;O

Cer 20:1;O2/10:0;O

C30H59NO4 (497.4444)


   

Cer 14:0;O2/16:1;O

Cer 14:0;O2/16:1;O

C30H59NO4 (497.4444)


   

Cer 14:0;O2/17:0

Cer 14:0;O2/17:0

C31H63NO3 (497.4808)


   

Cer 15:0;O2/16:0

Cer 15:0;O2/16:0

C31H63NO3 (497.4808)


   

Cer 16:0;O2/15:0

Cer 16:0;O2/15:0

C31H63NO3 (497.4808)


   

Cer 17:0;O2/14:0

Cer 17:0;O2/14:0

C31H63NO3 (497.4808)


   

Cer 18:0;O2/13:0

Cer 18:0;O2/13:0

C31H63NO3 (497.4808)


   

Cer 19:0;O2/12:0

Cer 19:0;O2/12:0

C31H63NO3 (497.4808)


   

Cer 20:0;O2/11:0

Cer 20:0;O2/11:0

C31H63NO3 (497.4808)


   

Cer 21:0;O2/10:0

Cer 21:0;O2/10:0

C31H63NO3 (497.4808)


   

Cer 9:0;O3/20:2;O

Cer 9:0;O3/20:2;O

C29H55NO5 (497.408)


   

Cer 14:0;O3/16:1

Cer 14:0;O3/16:1

C30H59NO4 (497.4444)


   

Cer 15:0;O3/15:1

Cer 15:0;O3/15:1

C30H59NO4 (497.4444)


   

Cer 16:0;O3/14:1

Cer 16:0;O3/14:1

C30H59NO4 (497.4444)


   
   

(2s,3s,4s)-4-amino-2-[(9z)-9-chlorohexacosa-5,9-dien-1-yl]oxolan-3-ol

(2s,3s,4s)-4-amino-2-[(9z)-9-chlorohexacosa-5,9-dien-1-yl]oxolan-3-ol

C30H56ClNO2 (497.3999)


   

Cer(d31:0)

Cer(d31:0)

C31H63NO3 (497.4808)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Cer(d17:0_14:0)

Cer(d17:0_14:0)

C31H63NO3 (497.4808)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Cer(t30:1)

Cer(t30:1)

C30H59NO4 (497.4444)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Cer(m33:6)

Cer(m33:6)

C33H55NO2 (497.4233)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved